162 related articles for article (PubMed ID: 2797013)
1. Asialo-GM1+ natural killer cells directly suppress antibody-producing B cells.
Robles CP; Pollack SB
Nat Immun Cell Growth Regul; 1989; 8(4):209-22. PubMed ID: 2797013
[TBL] [Abstract][Full Text] [Related]
2. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
Suzuki S; Suzuki R; Onta T; Kumagai K
Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
[TBL] [Abstract][Full Text] [Related]
3. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
4. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
5. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
[TBL] [Abstract][Full Text] [Related]
6. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
Knobloch C; Dennert G
J Immunol; 1988 Feb; 140(3):744-9. PubMed ID: 2448375
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
8. NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo.
Nishikado H; Mukai K; Kawano Y; Minegishi Y; Karasuyama H
J Immunol; 2011 May; 186(10):5766-71. PubMed ID: 21490162
[TBL] [Abstract][Full Text] [Related]
9. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
10. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
11. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
Suzuki R; Handa K; Itoh K; Kumagai K
J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
[TBL] [Abstract][Full Text] [Related]
16. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation.
Nilsson N; Carlsten H
Cell Immunol; 1994 Oct; 158(1):131-9. PubMed ID: 8087860
[TBL] [Abstract][Full Text] [Related]
17. Generation of natural killer cell lines from murine long-term bone marrow cultures.
Yung YP; Okumura K; Moore MA
J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of natural killer activity by calcitonin gene-related peptide.
Umeda Y; Arisawa M
Immunopharmacol Immunotoxicol; 1989; 11(2-3):309-20. PubMed ID: 2559931
[TBL] [Abstract][Full Text] [Related]
19. The in vivo role of murine natural killer cells in the development of B cell lineage in bone marrow.
Tamauchi H; Shimamura K; Okumura K; Habu S; Tamaoki N
Tokai J Exp Clin Med; 1985 Dec; 10(6):621-9. PubMed ID: 3915838
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the secondary in vitro antibody response by endogenous natural killer cells: kinetics, isotype preference, and non-identity with T suppressor cells.
Robles CP; Pollack SB
J Immunol; 1986 Oct; 137(8):2418-24. PubMed ID: 2944955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
